Australia · Delayed Price · Currency is AUD Mayne Pharma Group Company Description
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.
It operates through three segments: Women’s Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers.
It also distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas.
The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010.
Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
| Country | Australia |
| Founded | 2005 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 491 |
| CEO | Shawn O’Brien |
Contact Details
Address: 1538 Main North Road Salisbury South, Victoria 5106 Australia | |
| Phone | 61 8 8209 2666 |
| Website | maynepharma.com |
Stock Details
| Ticker Symbol | MYX |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000MYX0 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Shawn O’Brien | Chief Executive Officer |
| Aaron Gray | Chief Financial Officer |